만성정신분열병 환자들에서 비정상적 불수의 운동과 혈당, 지질과의 상관관계

키워드

참고문헌 (35)

1. "Diagnostic and StatisticalManual of Mental Disorders", pp.803~805 (2000), American Psychiatric Press
2. "Impaired Glucose tolerance and abnormalmovement in patients with schizophrenia", 156, pp.640~642 (1999)
3. "Low doseinsulin treatment of Tardive Dyskinesia"
4. "Neuroendocrineeffect of haloperidol therapy in chronic schizophrenia", pp.17~22
5. "PersistentTD and Neuroleptic effects on glucose tolerance", pp.17~27
6. "Possible association between tardive dyskinesia and alteredcarbohydrate metabolism"
7. "Physical consequences of schizophreniaand its treatment; the metabolic syndrome", pp.239~257
8. "Glucose suppresses basal firingand haloperidol- induced increases in the firing rate ofcentral dopaminergic neurons", pp.1269~1271
9. "Glucose metabolism in relation to schizophrenia and antipsychoticdrug treatment", 13, pp.103~113 (2001)
10. "Theprevalence of tardive dyskinesia in neuroleptic-treateddiabetics A controlled study", pp.259~263
11. "Antipsychotic medication: effectson regulation of glucose and lipids.", 2, pp.1571~1582 (2001)
12. "Neuroendocrine effects of haloperidol therapy inchronic schizophrenia", pp.17~22
13. "Conjugated HVA increasein rat urine after insulin-induced hypoglycemia involvementof central dopaminergic structures but not of adrenalmedulla", pp.121~138
14. "Dramatic worseningof type 2 diabetes mellitus due to olanzapine after 3 yearsof therapy", 21, pp.1444~1447 (2001)
15. "an elucidation of impaired neurometabolism", pp.420~435
16. "Hormonal aspects of schizophrenias:an overview", 28, pp.1~16 (2003)
17. "Modulation of dopaminereceptor supersensitivity by chronic insulin"
18. "National Institute of Mental Health", ab(rmal involuntary movementscale), pp.781~782
19. "Elevated levelsof insulin, leptine and blood lipids in olazapine treatedpatients with schizophrenia or related psychosis", 61, pp.742~749 (2000)
20. "항정신병약물 복용환자들의 Hyperlipidemia와hyperglycemia 이환율에 관한 예비연구", 13, pp.120~130 (2002)
21. "Association study of the estrogen receptor polymorphismswith tardive dyskinesia in schizophrenia", 46, pp.173~175 (2002)
22. "Hormonal aspects of schizophrenias:an overview", 28, pp.1~16 (2003)
23. "Regulation of exercise carbohydrate metabolismby estrogen and progesterone in women", 283, pp.1046~1055 (2002)
24. "Manual of clinicalpsychopharmacology" (2003), AmericanPsychiatric Publishing
25. "In Meltzer HY, Psychopharmacology.The Third ed", pp.1411~1419 (1997), Generation of prog-ress ,NY:Raven Press
26. "Risperidone-induced tardivedyskinesia and parkinsonism", 12, pp.119~121 (1997)
27. "Movementdisorders associated with atypical antipsychoticdrugs", 63, pp.12~19 (2002)
28. "The effects of clozapineon tardive dyskinesia", pp.503~510
29. "Extrapyramidal side effects, tardive dyskinesia,and the concept of atypicality", 61, pp.16~21 (2000)
30. "Tardive dyskinesiadue to Risperidone", 13, pp.107~108 (1998)
31. "Tardive dyskinesia caused by the atypicalantipsychotic risperidone and cured by the use ofanother drug of the same class Olanzapine", 16, pp.259~260 (2001)
32. "Olanzapine in the long-term treatment of schizophrenia", 174, pp.26~29 (1999)
33. "Dopamine receptorbinding is increased in diabetic rats", pp.1031~1033
34. "Dopamine agonists reverse the elevated3H-neuroleptic binding in neuroleptic-pretreatedrats", pp.1447~1452
35. "Clozapine, diabetes mellitus, weight gainand lipid abnormalities: A five year naturalistic study", 157, pp.975~981

관련 논문AI추천